Sawai GHD inherits the rights to warfarin tablets in the country.

On the 27th, Sawai GHD <4887.T> announced that the group's Sawai Pharmaceutical has signed a contract to inherit the rights to the pharmaceutical product Warfarin Tablets (generic name: Warfarin Potassium), manufactured and sold by Eisai <4523.T> in Japan. The oral anticoagulant "Warfarin" has been used for a long time in the treatment and prevention of many patients with thromboembolic diseases. With the conclusion of the contract, the company will pay Eisai 45 as compensation for the transfer.

Kabushiki ShimbunMar 27 00:21 ET

Sawai Group Holdings To Go Ex-Dividend On March 28th, 2025 With 27 JPY Dividend Per Share

March 27th (Japan Standard Time) - $Sawai Group Holdings(4887.JP)$ is trading ex-dividend on March 28th, 2025.Shareholders of record on March 31st, 2025 will receive 27 JPY dividend per share. The ex-

Moomoo NewsMar 26 21:00 ET

Sawai Group Holdings to Enhance Governance With New Supervisory Committee

TipRanksMar 24 02:22 ET

Express News | [Change Report] Silchester International reports a decrease in its shareholding of Sawai Group Holdings (4887.JP) to 5.72%.

Moomoo NewsMar 23 21:18 ET

Express News | [Change Report] Nomura Securities reported an increase in the shareholding ratio of Sawai Group Holdings (4887.JP) to 6.79%.

Moomoo NewsMar 20 22:57 ET

List of cloud break stocks (Part 2) [Ichimoku Kinko Hyo - List of cloud break stocks]

○ List of stocks below the cloud market Code Stock Name Closing Price Leading Span A Leading Span B Tokyo Stock Exchange Main Board <1801> Taisei Corporation 6451 6460.5 6574.5 <1941> Chudenko 31203221.25 3275 <1968> Taihei Electric 472548504950 <2153> Eiji HD 16161632.5 167.5 <2220> Kameda Confectionery 395039654010 <2

Fisco JapanMar 11 18:57 ET